He was most recently vice president of business development at ChayseChem, a privately held distributor whose assets were acquired by Charkit earlier this month. In conjunction with that acquisition, Klumph will now operate the ChayseChem business under the Charkit umbrella.
Before joining ChayseChem, he was at Novasep, a French-based contract manufacturing organization (CMO), where he served in a senior director business development capacity. At Novasep, Klumph was responsible for promoting their unique synthesis and purification technologies into all non-pharma markets throughout the US.
Earlier in his career, he worked in corporate purchasing at Troy Corporation and ISP, a company involved with butanediol and derivatives for various markets, industrial biocides, elastomers and other specialty chemicals. He also served in sales, marketing, and purchasing roles at FMC Corporation and SNPE North America, where he played a key role in working with NASA and the Defense Energy Support Center (DESC), the contracting entity for the U.S. Government, on supplying alkyl hydrazines for use as propellants in fighter jet ejection seats and the Orbital Maneuvering Systems (OMS) used in the Space Shuttle program.